7.37
0.11 (1.45%)
| Penutupan Terdahulu | 7.26 |
| Buka | 7.24 |
| Jumlah Dagangan | 946,441 |
| Purata Dagangan (3B) | 3,820,804 |
| Modal Pasaran | 1,600,404,352 |
| Harga / Pendapatan (P/E Ke hadapan) | 16.00 |
| Harga / Jualan (P/S) | 2.53 |
| Harga / Buku (P/B) | 1.06 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 Jan 2026 |
| Margin Keuntungan | -53.56% |
| Margin Operasi (TTM) | 2.45% |
| EPS Cair (TTM) | -2.23 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -3.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 33.61% |
| Nisbah Semasa (MRQ) | 3.91 |
| Aliran Tunai Operasi (OCF TTM) | 68.45 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.26 M |
| Pulangan Atas Aset (ROA TTM) | 0.59% |
| Pulangan Atas Ekuiti (ROE TTM) | -16.71% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menaik | Menaik |
| Diagnostics & Research (Global) | Menaik | Menaik | |
| Stok | Neogen Corporation | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.63 |
|
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 0.38% |
| % Dimiliki oleh Institusi | 128.88% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 12.00 (Guggenheim, 62.93%) | Beli |
| Median | 10.00 (35.78%) | |
| Rendah | 10.00 (Piper Sandler, 35.78%) | Pegang |
| 10.00 (CJS Securities, 35.78%) | Beli | |
| Purata | 10.67 (44.87%) | |
| Jumlah | 2 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 8.66 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Piper Sandler | 12 Jan 2026 | 10.00 (35.78%) | Pegang | 9.37 |
| Guggenheim | 09 Jan 2026 | 12.00 (62.93%) | Beli | 9.62 |
| CJS Securities | 10 Dec 2025 | 10.00 (35.78%) | Beli | 6.98 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 28 Jan 2026 | Pengumuman | Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution |
| 08 Jan 2026 | Pengumuman | Neogen Announces Second-Quarter 2026 Results |
| 05 Jan 2026 | Pengumuman | Neogen® Announces Two Senior Leadership Appointments |
| 18 Dec 2025 | Pengumuman | Neogen Announces Second-Quarter Earnings Release Date |
| 17 Dec 2025 | Pengumuman | Neogen® To Participate in Upcoming Investor Conferences |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |